Temperature-Controlled Storage of Investigational Drugs

The contract requires long-term refrigerated storage of investigational drugs in powder-in-sachet form, with strict adherence to temperature control protocols to ensure product integrity throughout the storage period. All handling procedures must comply with FDA regulations, including documentation, facility standards, and quality assurance measures to maintain the stability and safety of the investigational products. The facility must be capable of sustaining validated cold chain conditions and implementing robust monitoring systems to prevent any deviation that could compromise the drugs. This is a small business set-aside subcontract under NAICS code 493120, restricted to small businesses as defined by the SBA, with a response deadline of July 11, 2026. The place of performance is located in Frederick, Maryland, 21703, and the contract is issued by the National Institutes of Health under the Department of Health and Human Services. The solicitation was posted on July 2, 2026, and bidders must demonstrate capacity for secure, compliant, and continuous storage operations in alignment with federal standards for investigational pharmaceuticals.